Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
18 hedge funds and large institutions have $960K invested in Histogen Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
5% less funds holding
Funds holding: 19 → 18 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
57% less capital invested
Capital invested by funds: $2.21M → $960K (-$1.25M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$84.5K |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$41.4K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$27.5K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$26K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$124K |
| 2 |
VF
Virtu Financial
New York
|
-$39K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.2K |
| 4 |
Renaissance Technologies
New York
|
-$8.14K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8K |
HSTO Hedge Fund Activity: Q3 2020 in Review
18 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2020, worth a combined $960K — down 57% from $2.21M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of HSTO and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.
The largest buyer was United Capital Financial Advisors, adding an estimated $84.5K. The largest seller was Acadian Asset Management, cutting an estimated $124K.
- 18 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2020, down from 19 in Q2 2020.
- Funds reported $960K of Histogen Inc. Common Stock stock for Q3 2020, down 57% quarter-over-quarter.
- 3 funds opened new Histogen Inc. Common Stock positions in Q3 2020 and 4 closed out, a net change of -1 holder.
- The largest Histogen Inc. Common Stock buyer in Q3 2020 was United Capital Financial Advisors, an estimated $84.5K added.
- The largest Histogen Inc. Common Stock seller in Q3 2020 was Acadian Asset Management, an estimated $124K sold.
Based on aggregated 13F filings for Q3 2020.